Citation: Ra. Leppik et al., AGONIST FUNCTION AT THE HUMAN ALPHA(2A) ADRENOCEPTOR - ALLOSTERIC MODULATION BY AMILORIDES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 118-118
Citation: Ra. Leppik et al., ALLOSTERIC MODULATION OF [H-3]PRAZOSIN BINDING AT THE HUMAN ALPHA(1A)ADRENOCEPTOR, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 653-653
Authors:
LEPPIK RA
LAZARENO S
MYNETT A
BIRDSALL NJM
Citation: Ra. Leppik et al., CHARACTERIZATION OF THE ALLOSTERIC INTERACTIONS BETWEEN ANTAGONISTS AND AMILORIDE ANALOGS AT THE HUMAN ALPHA(2A)-ADRENERGIC RECEPTOR, Molecular pharmacology, 53(5), 1998, pp. 916-925
Authors:
LEPPIK RA
LAZARENO S
MYNETT A
BIRDSALL NJM
Citation: Ra. Leppik et al., THE ALLOSTERIC INTERACTIONS OF ANTAGONISTS WITH AMILORIDE ANALOGS AT THE HUMAN-ALPHA(2A)-ADRENOCEPTOR, British Journal of Pharmacology, 122, 1997, pp. 69-69
Authors:
FAIRHALL KM
MYNETT A
SMITH RG
ROBINSON ICAF
Citation: Km. Fairhall et al., CONSISTENT GH RESPONSES TO REPEATED INJECTIONS OF GH-RELEASING HEXAPEPTIDE (GHRP-6) AND THE NONPEPTIDE GH SECRETAGOGUE, L-692,585, Journal of Endocrinology, 145(3), 1995, pp. 417-426
Citation: Km. Fairhall et al., CENTRAL EFFECTS OF GROWTH HORMONE-RELEASING HEXAPEPTIDE (GHRP-6) ON GROWTH-HORMONE RELEASE ARE INHIBITED BY CENTRAL SOMATOSTATIN ACTION, Journal of Endocrinology, 144(3), 1995, pp. 555-560